InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,312.96
(
0.09%
)
US TECH 100
18,197.60
(
0.01%
)
Dow Jones
39,833.71
(
0.07%
)
Brent Oil
82.71
(
-0.98%
)
Bitcoin
69,673.30
(
-2.49%
)
Post# of 66
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Shizane

Send PM Follow Ignore
Followers 1
Posts 87
Boards Moderated 1
Alias Born 08/14/2013

Shizane

Re: Shizane post# 49

Monday, 09/09/2013 4:42:32 PM

Monday, September 09, 2013 4:42:32 PM

Post# of 66
NVAX - Currently Holding

Novavax, Inc. has a very interesting week.

Beginning on Wednesday, September 11, 2013 NVAX will present at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado the session, entitled “RSV F Protein Vaccine Is Well-Tolerated and Immunogenic in Elders,” will present data from the company’s recently completed Phase 1 clinical trial of its RSV vaccine candidate in healthy elderly adults. Also, on the 11th “Passive Immunization with RSV F Vaccine-Induced Polyclonal Antibodies Protect Cotton Rats from RSV A Challenge" will be presented, both sessions are scheduled to be presented from 11:00AM - 01:00PM.

Then on Thursday, September 12, 2013 President and CEO of NVAX Stanley C. Erck will present at the Stifel Nicolaus Healthcare Conference 2013 in Boston, Massachusetts @ 09:45AM.


Links for more information on the presentations.
Novavax, Inc. Events

SHIZANE





*Above statements are wholly my opinion (unless stated otherwise) and should be a taken as such

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up